Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: 8-Week Atopic Dermatitis (AD) Treatment Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an 8-week atopic dermatitis treatment completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Procter and Gamble | Conditions: Atopic Dermatitis Eczema | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17